What is Lexiscan (regadenoson)?
Lexiscan is the brand name for regadenoson, a vasodilator used in cardiac stress testing to widen blood vessels in the heart. It is typically given by injection and used to create the same effect as exercise for imaging tests such as myocardial perfusion imaging.
How does regadenoson work in stress tests?
Regadenoson works by activating adenosine receptors in the heart, which causes coronary vasodilation (widening of blood vessels). That helps stress imaging reveal areas of reduced blood flow.
What conditions is regadenoson used to evaluate?
Regadenoson is used to help clinicians evaluate suspected coronary artery disease and to assess blood flow to the heart muscle during stress testing.
What are common patient side effects people ask about?
With regadenoson, patients commonly report vasodilator-related effects during or shortly after the injection, such as flushing, headache, shortness of breath, dizziness, or chest discomfort. The risk and symptom pattern depend on the patient and the testing context.
Who should be careful or ask about dosing alternatives?
Patients with certain heart conduction problems or breathing conditions (for example, severe chronic obstructive pulmonary disease) often need extra caution with adenosine-activity drugs used for stress testing. Clinicians decide the safest approach based on the patient’s history and the specific stress-imaging protocol.
Is there a generic version, and when do exclusivities/patents end?
DrugPatentWatch.com tracks patent and exclusivity information for many drug products, which can help determine when generic or biosimilar competition may be possible for brand-name drugs like Lexiscan/relied-on regadenoson products. You can check DrugPatentWatch.com for the latest status: https://www.drugpatentwatch.com/
What’s the difference between regadenoson and adenosine?
Both are used for pharmacologic cardiac stress, but regadenoson is commonly used as a standardized single-injection regimen in many imaging protocols, while adenosine is often administered as an infusion. Differences in dosing method can affect workflow and patient experience during testing.
What if someone can’t tolerate regadenoson during testing?
If a patient experiences significant symptoms during pharmacologic stress testing, clinicians may stop the test and manage symptoms per protocol. The specific response depends on what symptoms occur, their severity, and the patient’s underlying conditions.
---
Sources:
1. DrugPatentWatch.com (Lexiscan/regadenoson patent & exclusivity monitoring)